May 09, 2024CorporateFDA Clears the Individualized Nomogram for Rika Plasma Donation SystemThe latest innovation is anticipated to increase collection volume without increasing collection time
March 19, 2024CorporateTerumo Blood and Cell Technologies partners with CiRA Foundation to develop automated iPS cell manufacturingiPS cell manufacturing organization researchers to integrate Terumo Blood and Cell Technologies’ Quantum Flex, expertise through collaboration
The Latest Materials Financial Results for FYE 3/2024 May 14, 2024 Financial Statements IFRS Financial Results for the Fiscal Year Ended March 31, 2024 (PDF 482.92 KB) Presentation Material The Future of Terumo "Our vision and the path to it" (PDF 1.54 MB) Financial Results for the Fiscal Year Ended March 31, 2024 (PDF 1.34 MB) Additional Information Corporate Data File (PDF 615.58 KB) Corporate Data File (Excel 390.59 KB) Financial Statements /investors/library/financial-statements Presentations /investors/library/presentations Terumo Report /investors/library/annual-reports Sustainability /sustainability Corporate Governance /about/governance Consolidated Financial Statements /investors/library/financial Adobe Reader is required for viewing PDF files. Download Adobe Reader